STRENGTHING CLINICAL TRIALS FOR CANADIANS
RENFORCEMENT DES ESSAIS CLINIQUES POUR LES CANADIENS
About
Executive Committee
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
Search for:
About
Executive Committee
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
Search for:
Team
Dr. Michelle Peel
Search for:
About
Executive Committee
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
